News & Events

New York, NY (November 9, 2023) - The Allen Discovery Center (ADC) for Neuroimmune Interactions at the Icahn School of Medicine at Mount Sinai hopes to revolutionize the field of medicine with a groundbreaking project to understand how the human body senses health and disease.

Spearheaded by Dr. Brian S. Kim of Mount Sinai and co-led by Dr. David...

A drug currently in clinical trials as a cancer therapy can also stimulate pancreatic beta cells to secrete insulin, revealing a previously unknown mechanism for insulin regulation in type 2 diabetes, according to a new study by Weill Cornell Medicine investigators. The preclinical discovery, reported Nov. 9 in Nature Chemical Biology, provides a new chemical tool for probing the biology of diabetes, and...

Researchers at Weill Cornell Medicine have uncovered a novel route to stimulate the growth of healthy insulin-producing pancreatic beta cells in a preclinical model of diabetes. The findings hold promise for future therapeutics that will improve the lives of individuals with type 2 diabetes—a condition that affects more than half a billion people worldwide.

This study, published in the Journal of Clinical Investigation on Sept. 15...

Researchers at Weill Cornell Medicine have demonstrated how amyloid beta, a peptide associated with Alzheimer’s disease, can interact with a protein receptor on immune cells in the brain triggering a reaction that damages blood vessels and leads to neurodegeneration.

The findings, published in Molecular Neurodegeneration on Oct. 3, may help researchers understand how dementia develops...

Researchers at Weill Cornell Medicine have led a phase 1 trial of a new drug that delivers potent radiation therapy directly and specifically to cancer cells in patients with advanced prostate cancer. The clinical trial showed that the “radiopharmaceutical” was well tolerated and demonstrated promising antitumor activity, according to a new study published on Nov. 3 in the Journal of Clinical Oncology.

The...

A surprising mechanism that makes some cancers treatment-resistant has been discovered by Weill Cornell Medicine and NewYork-Presbyterian investigators.  The mechanism, which involves the shuttling of messenger RNAs (mRNAs) from the nucleus to the cytoplasm, ultimately facilitates DNA repair in cancer cells. These cancer cells can thereby thwart treatments aimed at damaging their DNA.

In a project encompassing both fundamental research and...

Weill Cornell Medicine is expanding its real estate agreement at 575 Lexington Ave. to provide state-of-the-art clinical care at the Midtown Manhattan location by 2025.

The new space, which represents a 100,000-foot expansion of current space in the same building, will be renovated to support exceptional patient services in a well-situated midtown location with convenient access from Grand Central Terminal and three major subway lines.

“This expansion project is very exciting for...

Ambulance-based mobile stroke units (MSU) can reach patients faster to deliver clost-busting drugs that increase the likelihood of averting strokes and complete recovery compared with standard hospital emergency care, according to researchers at Weill Cornell Medicine, NewYork-Presbyterian, UTHealth Houston, Memorial Hermann-Texas Medical Center and five other medical centers across the United States.

The study,...

NEW YORK (Oct. 25, 2023) — Dr. Maya Hogg, a leading hospitalist, has been appointed chief of medicine at NewYork-Presbyterian Lower Manhattan Hospital and vice chair in the Weill Department of Medicine at Weill Cornell Medicine, effective Oct. 1.

As chief of medicine, Dr. Hogg will oversee inpatient and outpatient medical treatment at the hospital. She will increase patients’ access to high-quality care...

Certain gut-dwelling fungi flourish in severe cases of COVID-19, amplifying the excessive inflammation that drives this disease while also causing long-lasting changes in the immune system, according to a new study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian. This discovery identifies a group of patients who may benefit from specialized, but yet-to-be determined treatments.

Estrogen-based menopause hormone therapy for women in mid-life should be investigated more thoroughly as a potential strategy for preventing Alzheimer’s disease, the most common form of dementia, according to a new analysis from researchers at Weill Cornell Medicine.

The researchers, whose findings appear Oct. 23 in Frontiers in Aging Neuroscience, performed a meta-analysis of 6 clinical trials and 45...

Mental health crises among children and adolescents requiring emergency department care skyrocketed during the pandemic and have stayed elevated despite a return to normalcy, according to a study by Weill Cornell Medicine and NewYork-Presbyterian investigators.

The study, published in the journal Pediatrics on Oct. 20, compared rates of...

Dr. Iosif Gulkarov, a leading adult cardiac surgeon, has been appointed chief of cardiothoracic surgery at NewYork-Presbyterian Queens, effective Oct. 1. Dr. Gulkarov was also recruited to Weill Cornell Medicine as an associate professor of clinical cardiothoracic surgery.

In his new role, Dr. Gulkarov will continue to grow the cardiothoracic surgery program at NewYork-Presbyterian Queens through increased interdepartmental...

In experiments of unprecedented scale, investigators at Weill Cornell Medicine and the National Institutes of Health have revealed new aspects of the complex genetics behind Type 2 diabetes. Through these discoveries, and by providing a template for future studies, this research furthers efforts to better understand, and ultimately, treat this common metabolic disease.

Previous studies have generally examined the influence of individual genes. In...

NEW YORK (Oct. 17, 2023)—Weill Cornell Medicine is constructing a modern new student residence that, when it opens in 2025, will expand the scope of the institution’s Upper East Side campus and nearly double the existing student residential living space.

The new $260 million, 16-story, 173,000-square-foot...

An American Heart Association (AHA) Presidential Advisory, co-authored by a committee including the dean of Weill Cornell Medicine, outlines an ambitious plan to increase rigorous research on initiatives aimed at providing food as medicine for chronic conditions.

 Food is Medicine (FIM) is an increasingly popular approach to help treat or prevent chronic conditions by assisting patients to access healthier food...

Weill Cornell Medicine has been at the forefront of medical education since its inception, with a steadfast commitment to providing the best training for generations of physicians.

Founded in 1898, the institution—known at the time as Cornell University Medical College—sought to provide students with the opportunity to be more...

Dr. Lisa Newman, chief of the section of breast surgery at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, and Dr. Jedd D. Wolchok, the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell...

A Weill Cornell Medicine researcher has received a $610,000 grant from the Department of Defense to investigate the mechanisms causing DNA instability that potentially drives metastasis in bladder cancer. The research also aims to identify methods to intercept this spread. The Peer-Reviewed Cancer Research Program (PRCRP) Idea Award funds innovative, high-risk, high-reward basic cancer research. One of the goals of the PRCRP program is to decrease the burden of cancer on service members and...

Dr. Chenxu Zhu, an assistant professor of physiology and biophysics at Weill Cornell Medicine and a core faculty member of the New York Genome Center, has been awarded the National Institutes of Health Director’s New Innovator Award to fund an ambitious project to develop single-cell sequencing tools, known collectively as “multi-omics,” that...